Aditoprim

This classification denotes a dihydrofolate reductase inhibitor and anti-infective agent with the molecular formula C15H21N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Z81WDX2ZH, chemically known as 2,4-pyrimidinediamine, 5-((4-(dimethylamino)-3,5-dimethoxyphenyl)methyl)- but more generally known as aditoprim, which bears US NIH Compound Identifier 68755. European Medicines Agency schedules Aditoprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05275MIG. The term ADITOPRIM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 37, No. 6, 1983, List 23). ADITOPRIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C1C(N(C)C)C(OC)CC(CC2C(NC(NC2)N)N)C1)C.